中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2015
Turn off MathJax
Article Contents

Usage analysis of human serum albumin in patients with liver cancer and liver cirrhosis after hepatectomy

DOI: 10.3969/j.issn.1001-5256.2015.06.020
Research funding:

 

  • Published Date: 2015-06-20
  • Objective To analyze the usage of human serum albumin in patients with liver cancer and liver cirrhosis after hepatectomy.Methods A total of 121 patients with liver cancer and liver cirrhosis who received hepatectomy in our hospital from January 2012 to January2014 were divided into control group( n = 60) and observation group( n = 61). Both groups received human serum albumin in addition to the routine treatment for liver protection. The observation group was given intravenous drip of 5% human serum albumin within 48 h after surgery. The plasma albumin concentrations of patients were measured at 48 h after surgery,and if the concentration was < 35 g / L,the patients would be given 20% human serum albumin until the concentration was ≥35 g / L. The control group was given intravenous drip of 20%human serum albumin within 48 h after surgery until the plasma albumin concentration was ≥35 g / L. The amounts of used human serum albumin and plasma were recorded for both groups. The urine volume,abdominal drainage volume,central venous pressure( CVP),mean arterial pressure( MAP),and thromboelastogram( TEG) R and K values were measured at 1,3,7,and 10 days after surgery. The liver function indices before and after surgery and the indocyanine green retention rate at 15 minutes( ICG R15) at 7 days after surgery were measured. Comparison of continuous data between the two groups was made by t test,while comparison of categorical data was made by chisquare test. Results( 1) There were no significant differences in age,sex,Child- Pugh classification,surgical approach,intraoperative blood loss,occlusion time of the first porta hepatis,and operation time between the two groups( P > 0. 05). But there were significant differences in the amounts of used human serum albumin and plasma and the length of hospital stay between the two groups( P < 0. 05).( 2) There were significant differences in daily urine volume,CVP,MAP,abdominal drainage volume,and interstitial fluid volume at 1 and 3 days after surgery between the two groups( P < 0. 05),but there were no significant differences in the above indices at 7 days after surgery between the two groups( P > 0. 05). There were no significant differences in alanine aminotransferase,aspartate aminotransferase,total bilirubin,and TEG R and K values at 1 and 3 days after surgery between the two groups( P > 0. 05),but significant differences were observed in the above indices at 7 days after surgery( P < 0. 05).( 3) There was a significant difference in ICGR15 at 7 days after surgery between the observation group and the control group( 16. 59% ± 4. 4% vs 13. 21% ± 4. 2%,t = 5. 23,P = 0. 000). Conclusion The isotonic albumin and hypertonic albumin used in different periods after surgery have a better clinical effect than hypertonic albumin alone.

     

  • loading
  • [1]XU XH,XIANG XX,LONG AH,et al.Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer[J].J Clin Hepatol,2013,29(3):214-216.(in Chinese)许秀华,向晓星,龙爱华,等.原发性肝癌合并与不合并肝硬化患者年龄及乙型肝炎病毒血清学特点比较[J].临床肝胆病杂志,2013,29(3):214-216.
    [2]YANG M,NING H,YE LY,et al.Rational clinical application of human serum albumin[J].China Pharm,2014,23(6):88-91.(in Chinese)杨敏,宁红,叶琳燕,等.人血白蛋白的临床合理应用[J].中国药业,2014,23(6):88-91.
    [3]YAN Y,BO T.Efficacy of terlipressin combined with albumin in treatment of hepatorenal syndrome:a report of 35 cases[J].Chin J Integr Tradit West Med Liver Dis,2012,22(6):377-378.(in Chinese)闫勇,柏涛.特利加压素联合白蛋白治疗肝肾综合征35例[J].中西医结合肝病杂志,2012,22(6):377-378.
    [4]Chinese Expert Consensus Statement Chinese Society of Liver Cancer(CSLC),Chinese Society of Clinical Oncology(CSCO),Liver Cancer Group,Chinese Society of Hepatology.Consensus on standardized diagnosis and treatment of primary liver cancer[J].J Clin Hepatol,2009,25(2):83-92.(in Chinese)中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].临床肝胆病杂志,2009,25(2):83-92.
    [5]CESCON M,VETRONC G,GRAZI GL,et al.Trends in perioperative outcome after hepatic resection:analysis of 1500 consecutive unstleered cases over 20 years[J].Ann Surg,2009,249(6):995-1002.
    [6]LI QL,LI JD,XU W,et al.Factors related to continual hypoproteinemia after hepatectomy for patients with hepatocellular carcinoma[J].Chin J Digest Surg,2012,11(2):151-154.(in Chinese)李权林,李敬东,徐威,等.肝癌肝切除术后持续低蛋白血症的相关因素分析[J].中华消化外科杂志,2012,11(2):151-154.
    [6]GONG CG,WANG B,ZHAN Q,et al.Analysis of incidence and influencing factors of systemic inflammatory response syndrome after hepatectomy[J].J Pharm Pract,2012,30(5):361-364.(in Chinese)龚纯贵,王彬,战旗,等.肝切除术后全身性炎症反应发生率及其影响因素分析[J].药学实践杂志,2012,30(5):361-364.
    [7]PAN AJ,LIU B.Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients[J].Chin Critical Care Med,2013,25(1):59-61.(in Chinese)潘爱军,刘宝.欧洲危重病协会关于危重患者中胶体应用的共识[J].中国危重病急救医学,2013,25(1):59-61.
    [8]SCHRAMKO AA,SUOJARANTA-YLINEN RT,KUITUNEN AH,et al.Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery:a prospective randomized trial[J].Anesth Analg,2009,108(1):30-36.
    [9]ALVAREZ B,CARBALLAL S,TURELL L,et al.Formation andreactions of sulfenic acid in human serum albumin[J].Methods Enzymol,2010,56(473):117-136.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2087) PDF downloads(481) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return